Header Logo

Connection

Xueying YUAN to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Xueying YUAN has written about Xenograft Model Antitumor Assays.
Xueying YUAN
Connection Strength
0.128
Xenograft Model Antitumor Assays
  1. CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer. JCI Insight. 2024 Sep 17; 9(20).
    View in: PubMed
    Score: 0.128
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.